drugset / Trial / NCT06476821

A Study to Evaluate the Safety, Tolerability, Drug Levels, and Drug Effects of Single Doses of BMS-986435 (MYK-224) in Healthy Chinese Participants

NCT06476821

Phase 1 Completed 20 enrolled Bristol-Myers Squibb
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to assess the safety, tolerability, pharmacokinetics, and pharmacodynamics following a single oral dose of BMS-986435 in healthy adult Chinese participants.

Timeline

Start
2024-06-27
Primary completion
2024-10-11
Completion
2024-10-11

Drugs

EvaluationDrugModalityDoseRoute
Subject DELOCAMTEN Small molecule Oral

Indications

No indication recorded.